Project Grant HT94252410354
Award Date
7/1/24
Completion Date
6/30/27
Dollars Obligated
$816K
Federal Agency
Defense Health Agency
Federal Grant Program
12.420
Assistance Type
Project Grant
Place of Performance
Iowa City, IA 52242, USA
Similar Awards
The University of Iowa received a $816,178 Project Grant award from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420). The grant, titled "TARGETED THERAPY FOR MPNST METASTASIS," will support research activities at the University of Iowa from June 1, 2024 to May 31, 2027. The research aims to develop innovative treatments for metastatic malignant peripheral nerve sheath tumors, a rare and aggressive type of cancer. This federal grant...
The University of Iowa was awarded a $311,000 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program (CFDA 12.420) to conduct research on identifying the temporal and spatial origins and reversibility of neurodevelopmental disorders with autism in mouse models. The grant, awarded on June 1, 2024, will fund this research project through May 31, 2026. The Military Medical Research and Development program supports biomedical...
This Project Grant award of $894,125.00, provided by the Defense Health Agency under the Military Medical Research and Development (CFDA 12.420) program, supports research to understand and target epigenetic vulnerabilities in neurofibromatosis type 1-associated malignant peripheral nerve sheath tumors (NF1-MPNST) at Washington University. The research aims to transform healthcare for military service members, veterans, and the public by investigating innovative medical solutions. The 3-year...
The University of Iowa was awarded a $777,500.00 Project Grant from the Defense Health Agency to conduct research under the Military Medical Research and Development (CFDA 12.420) program. The grant, awarded on August 1, 2023, will fund a 3-year project to identify genetic mechanisms driving the transition of benign nevi to malignant melanoma. As a leading public research university, the University of Iowa has extensive experience delivering high-quality biomedical research, healthcare services,...
The University of Iowa received a $155,500 Project Grant award from the Department of the Army Medical Command under the Military Medical Research and Development (CFDA 12.420) federal grant program. The grant funding will support a targeted approach to inhibiting the NRF2 pathway in neuroendocrine cancers. This award, with a performance period from November 1, 2024 to October 31, 2026, is part of the program's efforts to transform healthcare for military service members and the general public...
The U.S. Department of Defense's Defense Health Agency has awarded a $2,268,386 Project Grant to the Jackson Laboratory in Bar Harbor, Maine to support the research project "Mapping the RNA Splicing Landscape of NF1 and Its Impact on Neurofibromin Function Across Tissues". This 3-year grant, running from August 1, 2025 to July 31, 2028, will fund research aimed at transforming healthcare for military service members, veterans, and the broader public by investigating innovative...
This $713,818 Project Grant awarded by the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by the Research Institute at Nationwide Children's Hospital in Columbus, Ohio to characterize novel patient-specific modeling systems for NF2 disease research and therapeutic testing. The project will be conducted from September 1, 2024 through August 31, 2027. The Research Institute has extensive experience delivering federal research...
The University of Iowa was awarded an $810,971 Project Grant from the Department of the Army Medical Command under the Military Medical Research and Development program. The award will fund research from April 2021 through April 2024 to target a protumorigenic immunosuppressive loop in malignant peripheral nerve sheath tumors (MPNST). The Military Medical Research and Development program supports biomedical research that transforms military and public health care through innovative solutions for...
This Project Grant award of $1,257,982.00 from the Defense Health Agency under the Military Medical Research and Development program (CFDA 12.420) supports research by The Regents of the University of California, San Francisco (UCSF) to map the RNA splicing landscape of NF1 and its impact on neurofibromin function across tissues. The 3-year award, which runs from August 1, 2025 to July 31, 2028, will advance the understanding of the genetic mechanisms underlying neurofibromatosis type 1, a...
The Department of Defense's Military Medical Research and Development program (CFDA 12.420) has awarded a $748,815 Project Grant to the University of Iowa. The grant, awarded on July 1, 2024, will support the "Women's Health in Tuberous Sclerosis Complex: A Population-Based Assessment of Morbidity to Inform Clinical Care" project. This research aims to provide a comprehensive assessment of the health issues faced by women with tuberous sclerosis complex, a rare genetic disorder, in...